Johnson & Johnson (JNJ) is expected to report their latest earnings on Tuesday before the market opens. In our June 22 review we wrote that "JNJ has been in an uptrend since 2012 but a decline to the $155 area in the weeks ahead could break that long-term trend." Prices have weakened but the $155 area has not been reached.
More from Investing
Let's look at why CVX's buyback news is a big deal for investors.
The dull market got a boost from Tesla, but this is not the kind of action we want to see.
PSX appears poised for further gains as earnings approach, according to the charts and indicators.
The situation for bitcoin investors right now is tough, but as we look at the crypto exchange-traded funds and the digital currency, I see one good 'option.'